Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-23

FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)

View source ↗

Summary

FDA approved a supplemental application for NARCAN nasal naloxone from Emergent Devices Inc., expanding the approved nasal formulation for opioid overdose treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NARCAN (Naloxone hydrochloride nasal)

Snippet

SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)